Infusio Glucosi Imuna

Glucose, the active ingredient in Infusio Glucosi Imuna, is an excipient / solvent presented as a solution for injection for intravenous use. It provides an energy source and raises blood glucose levels when administered intravenously, useful in hypoglycemia, fluid replacement and parenteral nutrition.

GNH USA supplies Infusio Glucosi Imuna as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Infusio Glucosi Imuna is used in clinical situations that require rapid glucose supplementation or fluid replacement.

Hypoglycemia: rapidly restores blood glucose to a safe range in patients with low plasma glucose. Fluid replacement: supplies isotonic fluid volume to support hydration and maintain circulatory stability. Parenteral nutrition: provides carbohydrate calories as part of total parenteral nutrition regimens for patients unable to receive enteral feeding.

Infusio Glucosi Imuna may be associated with several adverse reactions following intravenous administration.

Common Side Effects: - Hyperglycemia: transient elevation of blood glucose levels. - Phlebitis: inflammation of the vein at the infusion site. - Infiltration: leakage of solution into surrounding tissue. - Electrolyte imbalance: shifts in serum potassium or sodium. - Nausea or mild headache.

Serious or Rare Side Effects: - Severe hyperglycemia leading to osmotic diuresis. - Anaphylactic reaction: rare but potentially life‑threatening. - Volume overload causing pulmonary edema. - Metabolic acidosis in susceptible patients. - Infection at the catheter or infusion site.

When using Infusio Glucosi Imuna, clinicians should observe several safety measures. - Monitor blood glucose: check levels before and during infusion. - Adjust infusion rate: tailor to patient’s metabolic needs and clinical response. - Assess fluid status: avoid overload in patients with cardiac or renal impairment. - Use aseptic technique: prevent catheter‑related infections. - Contraindicated in uncontrolled diabetes without appropriate monitoring. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Glucose infusion can interact with other medications that affect glucose metabolism or fluid balance.

Major Interactions (Avoid): - Insulin: may cause severe hypoglycemia if not dose‑adjusted. - Diuretics: can exacerbate electrolyte disturbances. - Beta‑blockers: may mask symptoms of hypoglycemia.

Moderate Interactions (Monitor Closely): - Corticosteroids: increase blood glucose, requiring monitoring. - Catecholamines (e.g., epinephrine): raise glucose levels. - Oral hypoglycemic agents: may need dose adjustment during infusion.